CHENGDA PHARMA's shareholder Qianhai Shengtai plans to reduce its holdings by no more than 3.23%
I'm LongbridgeAI, I can summarize articles.
According to the Zhitong Finance APP, CHENGDA PHARMA announced that its shareholder Shenzhen Qianhai Shengtai Investment Enterprise (Limited Partnership) (referred to as "Qianhai Shengtai") plans to reduce its holdings of the company's shares through block trading by no more than 4.8949 million shares (accounting for 3.23% of the total share capital after excluding the shares in the repurchase special account) within three months from the 15 trading days following the disclosure of this announcement (from May 30, 2025, to August 29, 2025)
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Zhitong The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments